These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37071654)

  • 21. Introduction and Rapid Spread of SARS-CoV-2 Omicron Variant and Dynamics of BA.1 and BA.1.1 Sublineages, Finland, December 2021.
    Vauhkonen H; Nguyen PT; Kant R; Plyusnin I; Erdin M; Kurkela S; Liimatainen H; Ikonen N; Blomqvist S; Liitsola K; Lindh E; Helve O; Jarva H; Loginov R; Palva A; Hannunen T; Hannula S; Parry M; Kauppi P; Vaheri A; Sironen T; Lappalainen M; Savolainen-Kopra C; Smura T; Vapalahti O
    Emerg Infect Dis; 2022 Jun; 28(6):1229-1232. PubMed ID: 35378057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcomes and phylogenetic analysis in reflection with three predominant clades of SARS-CoV-2 variants.
    Ali KM; Rashid PMA; Ali AM; Tofiq AM; Salih GF; Dana OI; Rostam HM
    Eur J Clin Invest; 2023 Sep; 53(9):e14004. PubMed ID: 37036255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission.
    Shrestha LB; Foster C; Rawlinson W; Tedla N; Bull RA
    Rev Med Virol; 2022 Sep; 32(5):e2381. PubMed ID: 35856385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants.
    Selvavinayagam ST; Yong YK; Joseph N; Hemashree K; Tan HY; Zhang Y; Rajeshkumar M; Kumaresan A; Kalpana R; Kalaivani V; Monika AVD; Suvaithenamudhan S; Kannan M; Murugesan A; Narayanasamy K; Palani S; Larsson M; Shankar EM; Raju S
    Front Public Health; 2022; 10():1018399. PubMed ID: 36211690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multistate Outbreak of SARS-CoV-2 B.1.1.529 (Omicron) Variant Infections Among Persons in a Social Network Attending a Convention - New York City, November 18-December 20, 2021.
    Smith-Jeffcoat SE; Pomeroy MA; Sleweon S; Sami S; Ricaldi JN; Gebru Y; Walker B; Brady S; Christenberry M; Bart S; Vostok J; Meyer S; Seys S; Markelz A; Ditto N; Newbern V; Thomas FJ; Thomas D; Cabredo E; Kellner S; Brown VR; Tate JE; Kirking HL
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(7):238-242. PubMed ID: 35176004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
    Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
    PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative Dynamics of Delta and Omicron SARS-CoV-2 Variants across and between California and Mexico.
    Mehta SR; Smith DM; Boukadida C; Chaillon A
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing changes in incubation period, serial interval, and generation time of SARS-CoV-2 variants of concern: a systematic review and meta-analysis.
    Xu X; Wu Y; Kummer AG; Zhao Y; Hu Z; Wang Y; Liu H; Ajelli M; Yu H
    BMC Med; 2023 Sep; 21(1):374. PubMed ID: 37775772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Robust, Highly Multiplexed Mass Spectrometry Assay to Identify SARS-CoV-2 Variants.
    Hernandez MM; Banu R; Shrestha P; Gonzalez-Reiche AS; van de Guchte A; Farrugia K; Sebra R; ; Gitman MR; Nowak MD; Cordon-Cardo C; Simon V; van Bakel H; Sordillo EM; Luna N; Ramirez A; Castañeda SA; Patiño LH; Ballesteros N; Muñoz M; Ramírez JD; Paniz-Mondolfi AE
    Microbiol Spectr; 2022 Oct; 10(5):e0173622. PubMed ID: 36069609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2.
    Ward T; Glaser A; Overton CE; Carpenter B; Gent N; Seale AC
    Epidemiol Infect; 2022 Dec; 151():e32. PubMed ID: 36535802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study.
    Chen Z; Deng X; Fang L; Sun K; Wu Y; Che T; Zou J; Cai J; Liu H; Wang Y; Wang T; Tian Y; Zheng N; Yan X; Sun R; Xu X; Zhou X; Ge S; Liang Y; Yi L; Yang J; Zhang J; Ajelli M; Yu H
    medRxiv; 2022 Jun; ():. PubMed ID: 35765564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resurgence of SARS-CoV-2 Delta after Omicron variant superinfection in an immunocompromised pediatric patient.
    Alisoltani A; Simons LM; Agnes MFR; Heald-Sargent TA; Muller WJ; Kociolek LK; Hultquist JF; Lorenzo-Redondo R; Ozer EA
    Virol J; 2023 Oct; 20(1):246. PubMed ID: 37891657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of SARS-CoV-2 variants of concern over a period of Delta and Omicron cocirculation, among patients hospitalized for COVID-19 in an Italian reference hospital: Impact on clinical outcomes.
    Mondi A; Mastrorosa I; Piselli P; Cimaglia C; Matusali G; Carletti F; Giannico G; Milozzi E; Biliotti E; Di Bari S; Chinello P; Beccacece A; Faraglia F; Vittozzi P; Mosti S; Tetaj N; Stazi GV; Pinnetti C; Camici M; D'Annunzio A; Marani A; Fabeni L; Specchiarello E; Gruber CEM; Villanacci A; Minicucci S; Garbuglia AR; Ianniello S; Marchioni L; Taglietti F; D'Offizi G; Palmieri F; Nicastri E; Maggi F; Vaia F; Girardi E; Antinori A
    J Med Virol; 2023 Jun; 95(6):e28831. PubMed ID: 37246793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wastewater Genomic Surveillance Captures Early Detection of Omicron in Utah.
    Gupta P; Liao S; Ezekiel M; Novak N; Rossi A; LaCross N; Oakeson K; Rohrwasser A
    Microbiol Spectr; 2023 Jun; 11(3):e0039123. PubMed ID: 37154725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study.
    Lauring AS; Tenforde MW; Chappell JD; Gaglani M; Ginde AA; McNeal T; Ghamande S; Douin DJ; Talbot HK; Casey JD; Mohr NM; Zepeski A; Shapiro NI; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Exline MC; Gong MN; Mohamed A; Johnson NJ; Srinivasan V; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Halasa N; Grijalva CG; Rice TW; Stubblefield WB; Baughman A; Womack KN; Rhoads JP; Lindsell CJ; Hart KW; Zhu Y; Adams K; Schrag SJ; Olson SM; Kobayashi M; Verani JR; Patel MM; Self WH;
    BMJ; 2022 Mar; 376():e069761. PubMed ID: 35264324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular evolution of SARS-CoV-2 from December 2019 to August 2022.
    Wolf JM; Wolf LM; Bello GL; Maccari JG; Nasi LA
    J Med Virol; 2023 Jan; 95(1):e28366. PubMed ID: 36458547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 wastewater monitoring using a novel PCR-based method rapidly captured the Delta-to-Omicron ΒΑ.1 transition patterns in the absence of conventional surveillance evidence.
    Chassalevris T; Chaintoutis SC; Koureas M; Petala M; Moutou E; Beta C; Kyritsi M; Hadjichristodoulou C; Kostoglou M; Karapantsios T; Papadopoulos A; Papaioannou N; Dovas CI
    Sci Total Environ; 2022 Oct; 844():156932. PubMed ID: 35753493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of SARS-Cov-2 omicron variant with the previously identified SARS-Cov-2 variants in Egypt, 2020-2022: insight into SARS-Cov-2 genome evolution and its impact on epidemiology, clinical picture, disease severity, and mortality.
    Kandeel A; Moatasim Y; Fahim M; Bahaaeldin H; El-Shesheny R; Roshdy WH; Kamel MN; Shawky S; Gomaa M; Naguib A; Guindy NE; Deghedy O; Kamel R; Khalifa M; Galal R; Hassany M; Mahmoud G; Kandeil A; Afifi S; Mohsen A; Fattah MA; Kayali G; Ali MA; Abdelghaffar K
    BMC Infect Dis; 2023 Aug; 23(1):542. PubMed ID: 37596534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics.
    Meo SA; Meo AS; Al-Jassir FF; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8012-8018. PubMed ID: 34982465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants - United States, June 2021-January 2022.
    Lambrou AS; Shirk P; Steele MK; Paul P; Paden CR; Cadwell B; Reese HE; Aoki Y; Hassell N; Zheng XY; Talarico S; Chen JC; Oberste MS; Batra D; McMullan LK; Halpin AL; Galloway SE; MacCannell DR; Kondor R; Barnes J; MacNeil A; Silk BJ; Dugan VG; Scobie HM; Wentworth DE; Caravas J; Kovacs NA; Gerhart JG; Jia Ng H; Beck A; Chau R; Cintron R; Cook PW; Gulvik CA; Howard D; Jang Y; Knipe K; Lacek KA; Moser KA; Paskey AC; Rambo-Martin BL; Nagilla RR; Retchless AC; Schmerer MW; Seby S; Shepard SS; Stanton RA; Stark TJ; Uehara A; Unoarumhi Y; Bentz ML; Burgin A; Burroughs M; Davis ML; Keller MW; Keong LM; Le SS; Lee JS; Madden Jr JC; Nobles S; Owuor DC; Padilla J; Sheth M; Wilson MM; ;
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):206-211. PubMed ID: 35143464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.